ReviewPediatric cardiology2012
A contemporary assessment of the risk for sudden cardiac death in patients with congenital heart disease.
Review in Pediatric cardiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 47 citations in OpenAlex.
- Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Surgically Repaired Tetralogy of Fallot.Pediatric cardiology · 2026Article
- Born to Age: When Adult Congenital Heart Disease Converges With Geroscience.JACC. Advances · 2022Review
- An Imaging Protocol to Discriminate Specialized Conduction Tissue During Congenital Heart Surgery.Seminars in thoracic and cardiovascular surgery · 2019Article
- The clinical characteristics of sudden cardiac arrest in asymptomatic patients with congenital heart disease.Heart and vessels · 2015Article
- Arrhythmias in structural heart disease.Current cardiology reports · 2014Review
- Prevalence and spectrum of PITX2c mutations associated with congenital heart disease.DNA and cell biology · 2013Article
- Management of late arrhythmias in adults with repaired congenital heart disease.Current treatment options in cardiovascular medicine · 2013Article
- Physical activity recommendations for patients with electrophysiologic and structural congenital heart disease: a survey of Canadian health care providers.Pediatric cardiology · 2013Article
- GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect.Pediatric cardiology · 2013Article
- PITX2c loss-of-function mutations responsible for congenital atrial septal defects.International journal of medical sciences · 2013Article
- GATA5 loss-of-function mutations underlie tetralogy of fallot.International journal of medical sciences · 2013Article
- Novel GATA6 mutations associated with congenital ventricular septal defect or tetralogy of fallot.DNA and cell biology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Assessment of the risk for sudden cardiac death (SCD) after surgery for congenital heart disease (CHD) remains a difficult challenge. In the study of this problem, the focus has evolved from concern regarding late-onset heart block to a subsequent focus on ventricular and reentrant atrial arrhythmias, with the most recent emphasis on ventricular dysfunction and heart failure. Sudden cardiac death in CHD patients has been studied most extensively in tetralogy of Fallot. More than 30 risk factors have been proposed, with age at repair, QRS duration, right ventricular enlargement, and left ventricular dysfunction considered the most predictive risk factors. Additionally, SCD has been studied in patients with atrial repair for transposition of the great arteries, left heart obstructive lesions, and to a limited extent, patients with univentricular physiology. This review discusses current risk factors for SCD in CHD and the limited positive predictive value of any individual factor. The emphasis is on contemporary patients with CHD, who differ markedly from those who had repair of CHD decades earlier. This is characterized by complete repairs during the neonatal period, improved physiologic outcomes, and extended survival of patients with complex forms of CHD. Therefore, earlier data and conclusions may not be relevant to newer generations of patients with CHD. According to current perspectives, systemic ventricular dysfunction becomes a major risk factor beyond the age of 20 years. The first symptomatic arrhythmia may result in SCD, and defibrillators are increasingly implanted despite the lack of risk stratification criteria. The large number of potential risk factors and therapeutic options, in contrast to the low incidence of actual events, results in a difficult clinical challenge in the assessment of the risk for SCD in the individual patient with CHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.